Search

Background: Burning mouth syndrome (BMS) is an intraoral burning or dysaesthetic sensation, recurring daily for more than two hours during the period longer than 3 months. The objective was to evaluate and analyse the efficacy of serotonin reuptake inhibitor fluoxetine on psychological factors, as well as on pain in participants with BMS. Methods: In a 6-month study, 100 participants with primary and secondary BMS were divided into two groups-fluoxetine and control (placebo) and examined by the dentist and the neurologist. Depression and anxiety were estimated by Hamilton Scale for Depression (HAM-D) and Anxiety (HAM-A) and Beck Depression Inventory (BDI) and the pain intensity by visual analogue scale (VAS). Results: Mean age of the participants was 60.33 in fluoxetine group and 67.4 in control group. Most of the participants were female-74% in the fluoxetine and 78% in the control group. Statistical difference between the fluoxetine and the control group was found in HAM-D results (P lt .05). Values of other scales and VAS decreased significantly after the therapy in both groups (P lt .05). Conclusions: Our trial results indicate that fluoxetine therapy not only improves the psychological status of participants with BMS but also fluoxetine decreases the intensity of pain in these patients.

The aim of this study was to assess whether polymorphisms in toll-like receptor (TLR) and cluster of differentiation 14 (CD14) genes are associated with oral lichen planus (OLP) risk and clinical course of the disease. The study group consisted of 101 patients with confirmed OLP and 104 healthy blood donors without systemic or oral mucosal diseases. Single nucleotide polymorphisms of TLR2 (rs3804099), TLR3 (rs3775291 and rs5743312), TLR4 (rs4986790 and rs4986791), and CD14 (rs2569190) genes were genotyped using real-time PCR or PCR-restriction fragment length polymorphism (PCR-RFLP). The rs5743312 TLR3 gene polymorphism was associated with increased OLP risk in comparison with the wild type genotype (OR = 15.984, P = 0.011). No association with OLP risk was observed for the polymorphisms studied in TLR2, TLR4 and CD14 genes or for the rs3775291 polymorphism of the TLR3 gene. The polymorphisms of the TLR3 gene were in linkage disequilibrium (D ' = 1, r(2) = 0.1). Identified haplotypes were not associated with the risk of OLP. The findings of the current study suggest that the TT genotype of the rs5743312 TLR3 gene polymorphism may play a significant role in the aetiology of OLP.

Burning mouth syndrome (BMS) is an intraoral burning sensation for which no medical or dental cause can be found. Recent studies suggest that primary neuropathic dysfunction might be involved in the pathogenesis of BMS. Calcitonin gene-related peptide (CGRP) plays an important role in the development of pain and serves as a biological marker of trigeminovascular activation. The aim of this study was to determine the levels of CGRP in the saliva of BMS patients and estimate the trigeminovascular activation in BMS. CGRP levels were measured, by RIA method in 78 BMS patients and 16 healthy subjects. The levels of CGRP were non-significantly decreased in BMS patients in comparison to healthy subjects. These results suggest that trigeminal nerve degeneration may be the underlying cause of BMS.

The current study investigated the association between VDR EcoRV (rs4516035), FokI (rs2228570), ApaI (rs7975232) and TaqI (rs731236), CYP27B1 (rs4646536), CYP24A1 (rs2296241), and MTHFR (rs1801133) gene polymorphisms and risk of oral lichen planus (OLP) occurrence. The study group consisted of 65 oral lichen planus patients and 100 healthy blood donors in the control group. Single nucleotide polymorphisms were genotyped by real time PCR or PCR-restriction fragment length polymorphism (RFLP) method. Heterozygous as well as mutated genotype of vitamin D receptor (VDR) FokI (rs2228570) polymorphism was associated with increased oral lichen planus risk in comparison with wild type genotype (odds ratio (OR) = 3.877, p = 0.017, OR = 38.153, p = 0.001, respectively). A significantly decreased OLP risk was observed for heterozygous genotype of rs2296241 polymorphism in CYP24A1 gene compared with the wild type form (OR = 0.314, p = 0.012). VDR gene polymorphisms ApaI and TaqI were in linkage disequilibrium (D’ = 0.71, r 2 = 0.22). Identified haplotype AT was associated with decreased OLP risk (OR = 0.592, p = 0.047). Our results highlight the possible important role of VDR FokI (rs2228570) and CYP24A1 rs2296241 gene polymorphisms for oral lichen planus susceptibility. Identification of new molecular biomarkers could potentially contribute to determination of individuals with OLP predisposition.

Clinic for Anesthesiology, Military Medical Academy, Belgrade, SerbiaOBJECTIVES: This study examined the single nucleotidepolymorphisms (SNPs) in high-mobility group box 1(HMGB1) gene in patients with oral squamous cell carci-noma (OSCC) and oral lichen planus (OLP).MATERIALS AND METHODS: The study was con-ducted on 93 patients with OSCC, 53 patients withOLP, and 100 controls, all Caucasians of the same eth-nicity, matched by age. HMGB1 genotypes for 4 SNPs,2262G/A (rs1045411), 1177G/C (rs3742305), 3814C/G(rs2249825), and rs4540927, were assessed using Taq-Man SNP Genotyping Assays, Applied Biosystems.RESULTS: The HMGB1 1177GG genotype was associ-ated with lymph-node metastasis and tumor stage inOSCCs (P=0.016 and P=0.030, respectively). Geno-type 1177GG resulted in poorer recurrence-free survival(RFS), P=0.000. The 1177G/C polymorphism was anindependent predictor of RFS compared to GG geno-type, P=0.001. The three polymorphisms were in link-age disequilibrium (LD). The AGC and GGC haplotypeswere associated with an increased oral cancer risk,determined over the haplotype odds ratios(HOR = 13.316, P = 0.015, and HOR = 5.769, P = 0.029,respectively). The AGC haplotype was related to ero-sive OLP progression to OSCC (HOR = 12.179,P = 0.001).CONCLUSIONS: HMGB1 polymorphism 1177G/C couldbe associated with tumor progression and recurrence-free survival in patients with OSCC. The haplotypes ofHMGB1 gene might be associated with susceptibility toOSCC and OLP progression to OSCC.Oral Diseases (2015) doi: 10.1111/odi.12318Keywords: oral squamous cell carcinoma; oral lichen planus;high-mobility group box 1; single nucleotide polymorphisms;recurrence-free survival; haplotypes